Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

TPE:1720 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	6,911	6,789	6,240	5,851	4,604	4,305
Revenue Growth (YoY)	3.02%	8.81%	6.64%	27.09%	6.94%	9.35%
Cost of Revenue	3,998	3,801	3,514	3,364	2,536	2,386
Gross Profit	2,912	2,989	2,725	2,488	2,068	1,920
Selling, General & Admin	1,300	1,293	1,209	1,100	948.47	992.48
Research & Development	273.84	288.09	266.27	251.88	241.79	227.21
Operating Expenses	1,567	1,592	1,466	1,369	1,191	1,213
Operating Income	1,345	1,397	1,260	1,118	876.83	706.63
Interest Expense	-8.03	-15.07	-25.42	-18.78	-7.25	-7.57
Interest & Investment Income	120.51	50.48	76.84	39.45	24.99	26.52
Earnings From Equity Investments	-7.91	-11.36	41.56	61.37	-6.16	3.05
Currency Exchange Gain (Loss)	-24.78	86.85	5.62	170.44	-25.6	-33.07
Other Non Operating Income (Expenses)	45.43	51.08	30.1	35.44	77.66	77.29
EBT Excluding Unusual Items	1,471	1,558	1,388	1,406	940.47	772.85
Gain (Loss) on Sale of Investments	9.53	-0.67	5.53	1.36	1.46	0.2
Gain (Loss) on Sale of Assets	-1.27	-5.47	1.27	-7.78	73.78	-0.08
Asset Writedown	-	-	-	-	-1.81	-
Other Unusual Items	0.12	-0.19	0.02	0.11	-66.45	-0.04
Pretax Income	1,479	1,627	1,438	1,400	1,014	772.93
Income Tax Expense	248.11	333.05	279.94	246.31	176.95	147.37
Earnings From Continuing Operations	1,231	1,294	1,158	1,154	836.8	625.56
Minority Interest in Earnings	-337.85	-413.81	-323.04	-338.21	-130.07	-101.39
Net Income	893.09	880.5	834.89	815.41	706.73	524.17
Net Income to Common	893.09	880.5	834.89	815.41	706.73	524.17
Net Income Growth	5.37%	5.46%	2.39%	15.38%	34.83%	39.23%
Shares Outstanding (Basic)	179	179	179	179	179	179
Shares Outstanding (Diluted)	179	179	179	179	179	179
Shares Change (YoY)	0.01%	0.01%	0.00%	-0.02%	0.02%	0.01%
EPS (Basic)	5.00	4.93	4.67	4.56	3.95	2.93
EPS (Diluted)	5.00	4.92	4.67	4.56	3.95	2.93
EPS Growth	5.44%	5.35%	2.41%	15.44%	34.81%	39.52%
Free Cash Flow	1,175	1,098	710.83	31.78	613.56	570.06
Free Cash Flow Per Share	6.57	6.14	3.97	0.18	3.43	3.19
Dividend Per Share	2.800	2.800	2.700	2.500	2.500	1.800
Dividend Growth	3.70%	3.70%	8.00%	-	38.89%	20.00%
Gross Margin	42.14%	44.02%	43.68%	42.51%	44.91%	44.59%
Operating Margin	19.47%	20.57%	20.19%	19.11%	19.05%	16.41%
Profit Margin	12.92%	12.97%	13.38%	13.94%	15.35%	12.17%
Free Cash Flow Margin	17.00%	16.18%	11.39%	0.54%	13.33%	13.24%
EBITDA	1,742	1,772	1,579	1,389	1,073	917.22
EBITDA Margin	25.21%	26.09%	25.30%	23.74%	23.31%	21.30%
D&A For EBITDA	396.94	375.06	319.44	270.67	196.31	210.59
EBIT	1,345	1,397	1,260	1,118	876.83	706.63
EBIT Margin	19.47%	20.57%	20.19%	19.11%	19.05%	16.41%
Effective Tax Rate	16.78%	20.47%	19.47%	17.59%	17.46%	19.07%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.